VERV

Verve Therapeutics

Delisted

VERV was delisted on the 24th of July, 2025.

125 hedge funds and large institutions have $2.08B invested in Verve Therapeutics in 2022 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 16 reducing their positions, and 21 closing their positions.

Holders
125
Holders Change
+24
Holders Change %
+23.76%
% of All Funds
2.16%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
45
Increased
55
Reduced
16
Closed
21
Calls
$16M
Puts
$4.26M
Net Calls
+$11.7M
Net Calls Change
+$8.05M
Name Market Value Shares Shares
Change
Shares
Change %
TFP
151
Tilia Fiduciary Partners
North Carolina
$0 14 +14 New